Tony Mazzulli^1,2

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 42-48, 2012

Abstract Urinary tract infections (UTIs) remain a common clinical problem in both the community and healthcare-associated settings. Each patient should be carefully assessed to ensure that a correct diagnosis is made and that antimicrobial therapy is appropriately prescribed—defined as using a clinically indicated agent in the correct dose and route of administration, for the correct duration—for symptomatic patients, and avoided for most asymptomatic patients. This should help stem the growing tide of antimicrobial resistance and allow for the continued use of simpler, less expensive agents. Continued surveillance and monitoring of antimicrobial resistance rates will be critical More >

Roland I. Sing, Rajiv K. Singal

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 36-41, 2012

Abstract Hematuria is a common finding in primary care practice. Causes of significant hematuria include urinary tract infection, urolithiasis, malignancies, benign prostatic hyperplasia, and nephropathies. Hematuria is identified by taking a patient history and by performing a routine urine dipstick test. If a patient has a history of gross hematuria and/or a positive urine dipstick test, he or she should then have a microscopic urinalysis. The primary care physician can order ancillary tests such as laboratory tests to assess renal function, and possible imaging tests such as ultrasound, computed tomography urography, or magnetic resonance urography. The More >

Sabeer Rehsia, Bobby Shayegan

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 28-35, 2012

Abstract Prostate cancer remains a common cancer diagnosis and cause of cancer-related death in men. Despite it’s high prevalence, screening for prostate cancer for early detection remains controversial. This article outlines evidence from contemporary prostate cancer screening clinical trials and presents an overview of therapeutic options across the spectrum of prostate-cancer states. More >

Michael B. Greenspan¹, Jack Barkin²

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 18-27, 2012

Abstract Erectile dysfunction (ED) and testosterone deficiency syndrome (TDS) are closely related. In addition to affecting men’s sexual health, both conditions also affect other male health issues. Screening for ED, especially in younger men, should become standard clinical practice for the primary care physician. Possible systemic effects and associated effects of TDS are now well documented. Testosterone replacement therapy (TRT) is very safe and effective in the right man. More >

Anil Kapoor

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 10-17, 2012

Abstract Benign prostate hyperplasia (BPH) occurs in up to 50% of men by age 50, and the incidence increases with age. This common clinical problem is diagnosed by history, including the International Prostate Symptom Score (IPSS) questionnaire, and physical examination by digital rectal examination (DRE).
Initial management for BPH includes lifestyle modification, and smooth muscle relaxant alpha blocker therapy. Alpha blockers usually take effect quickly within 3-5 days, and have minimal side effects. Current commonly used alpha blockers include the selective alpha blockers tamsulosin (Flomax), alfusosin (Xatral), and silodosin (Rapaflo). For patients with larger prostates, the… More >

Sidney B. Radomski¹, Jack Barkin²

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 2-9, 2012

Abstract Overactive bladder (OAB) with or without urinary incontinence is a common condition in both men and women. OAB has a signifcant impact on quality of life for most patients. In most cases, sophisticated testing is not required for a primary care physician to diagnose OAB and start treating a patient. Management of OAB requires behavioral modifcation and, if necessary, pharmacotherapy may be added. If a patient does not respond to treatment initiated by a primary care physician, then he or she should be referred to a specialist in OAB to undergo further investigations and treatments. More >

Jack Barkin

Canadian Journal of Urology, Vol.19, Suppl.5, pp. 1-1, 2012

Abstract This article has no abstract. More >

Can Talug¹, David Y. Josephson¹, Nora H. Ruel², Clayton Lau¹, Mark H. Kawachi¹, Timothy G. Wilson¹

Canadian Journal of Urology, Vol.19, No.1, pp. 6147-6154, 2012

Abstract Introduction: The objective of our study was to determine whether the dorsal venous complex (DVC) control technique influences positive apical margins following robotic-assisted laparoscopic radical prostatectomy (RALRP).
Materials and methods: A total of 1058 patients who underwent RALRP at City of Hope between June 2007 and October 2009 were included in the analysis. Endoscopic stapling and suture ligation of the DVC were compared. Positive apical margins were identified and compared based on the DVC control technique. Recurrence probability was estimated using the Kaplan-Meier method, and logistic regression analysis was used to predict the odds of positive apical margins.
… More >

Ashis Chawla, Adnan Qureshi, Aziz Alamri, Edward D. Matsumoto

Canadian Journal of Urology, Vol.19, No.1, pp. 6142-6146, 2012

Abstract Introduction: Placement of anterior abdominal wall trocars during laparoscopic radical prostatectomy (LRP) carries the risk of inadvertent injury to the inferior epigastric artery (IEA) and potential conflict between midline and lateral ports. We described and evaluated a new measured port placement approach.
Materials and methods: The intervention group included patients who underwent LRP using a specifically measured five-port approach. The medial 10 mm ports were placed 5 cm from the patient’s midline at a level midway between the anterior superior iliac spine (ASIS) and the umbilicus. The control group had five ports placed at the surgeon’s discretion.… More >

George Rodrigues, Eric Winquist

Canadian Journal of Urology, Vol.19, No.1, pp. 6135-6141, 2012

Abstract This article has no abstract. More >